Related Experiment Video
Updated: May 12, 2026

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells
Published on: August 29, 2020
Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3
Joerg Betschinger1, Jennifer Nichols, Sabine Dietmann
1Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge CB2 1QR, UK. jb579@cam.ac.uk
Abstract:
Factors that sustain self-renewal of mouse embryonic stem cells (ESCs) are well described. In contrast, the machinery regulating exit from pluripotency is ill defined. In a large-scale small interfering RNA (siRNA) screen, we found that knockdown of the tumor suppressors Folliculin (Flcn) and Tsc2 prevent ESC commitment. Tsc2 lies upstream of mammalian target of rapamycin (mTOR), whereas Flcn acts downstream and in parallel. Flcn with its interaction partners Fnip1 and Fnip2 drives differentiation by restricting nuclear localization and activity of the bHLH transcription factor Tfe3. Conversely, enforced nuclear Tfe3 enables ESCs to withstand differentiation conditions. Genome-wide location and functional analyses showed that Tfe3 directly integrates into the pluripotency circuitry through transcriptional regulation of Esrrb. These findings identify a cell-intrinsic rheostat for destabilizing ground-state pluripotency to allow lineage commitment. Congruently, stage-specific subcellular relocalization of Tfe3 suggests that Flcn-Fnip1/2 contributes to developmental progression of the pluripotent epiblast in vivo.
Insights
Tumor suppressors Folliculin (Flcn) and Tsc2 prevent embryonic stem cell (ESC) commitment by regulating Tfe3. Enforced nuclear Tfe3 maintains pluripotency, revealing a rheostat for lineage commitment.
Area of Science:
- Stem cell biology
- Molecular mechanisms of pluripotency
- Cell fate determination
Background:
- Self-renewal of mouse embryonic stem cells (ESCs) is well-understood.
- The molecular machinery controlling exit from pluripotency remains poorly defined.
Purpose of the Study:
- To identify factors regulating exit from pluripotency in ESCs.
- To elucidate the role of Folliculin (Flcn) and Tsc2 in ESC commitment.
Main Methods:
- Large-scale small interfering RNA (siRNA) screen.
- Analysis of mammalian target of rapamycin (mTOR) pathway.
- Investigation of transcription factor Tfe3 localization and activity.
- Genome-wide location and functional analyses.
- In vivo studies of epiblast development.
Main Results:
- Knockdown of Flcn and Tsc2 prevents ESC commitment.
- Flcn, with Fnip1/2, restricts nuclear Tfe3, promoting differentiation.
- Enforced nuclear Tfe3 allows ESCs to resist differentiation.
- Tfe3 directly regulates Esrrb, integrating into the pluripotency circuitry.
- Flcn-Fnip1/2 influences Tfe3 localization during in vivo development.
Conclusions:
- Flcn-Tsc2-mTOR pathway and Flcn-Fnip1/2-Tfe3 axis act as a cell-intrinsic rheostat for pluripotency destabilization.
- Tfe3 is a key regulator integrating pluripotency and differentiation.
- Flcn-mediated regulation of Tfe3 is crucial for developmental progression of the epiblast.
Related Concept Videos
Maintenance of the ES Cell State
Somatic to iPS Cell Reprogramming
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
General Transcription Factors
Transcription Factors
TGF - β Signaling Pathway
